“Most users tolerate GLP-1 medications like Ozempic without serious oral health issues, but a subset experience notable side ...

Amanda Bynes is showing off her new look, revealing to her followers that she recently received lip injections to plump up ...

Serena Williams' suggestion that injectable weight loss drugs could have helped her in tennis is part of an ongoing ...

Discover why Hims & Hers Health's subscriber growth, profitability, and telehealth expansion make it a strong buy with a ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...

GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.

The Danish drugmaker missed the goal in two phase 3 studies for CagriSema, an investigational combination of amylin analog cagrilintide and GLP-1 drug semaglutide.

And though Hers’s compounded semaglutide is not FDA-approved, she says that every compounded GLP-1 available through the online platform is “made with active pharmaceutical ingredients (APIs ...

That changed with Ozempic, the brand name for semaglutide, Novo Nordisk’s synthetic version of a hormone known as glucagon-like peptide 1, or GLP-1, which helps the body regulate blood sugar levels.

Morley shared: “Novo Nordisk’s oral semaglutide for obesity and Eli Lilly’s orforglipron calcium’s approvals would represent the first oral GLP-1RAs for obesity. “While both products are expected to ...

Weight-loss injections like Mounjaro (tirzepatide) and Wegovy (semaglutide) have gained widespread attention over the past few years as an effective new treatment for weight loss for those living with ...